Greenway Partners With Lightbeam to Bring Population Health and Data Solutions to Their Customers

IRVING, Texas, Sept. 3, 2014-- Lightbeam Health Solutions, LLC today announced it has joined the Greenway Health online Marketplace of value-added partners for users of Greenway's integrated Electronic Health Record (EHR) and practice management solutions.

Being named a Marketplace-approved partner signifies cooperative efforts between Lightbeam Health and Greenway to provide comprehensive, mission-critical health IT solutions that support the delivery of high-quality, cost-effective care.

The Lightbeam platform is an analytics breakthrough for healthcare providers, their patients, and payers. It's unique because improved patient outcomes are real and measurable. It's unique because it's a living outcome of our understanding of the challenges providers and payers face, complimented by our passion for analytics. Healthcare is changing. And the change isn't just about transitioning to a value-based environment. It's about leading the transformation of a culture. We at Lightbeam believe deeply in the transformational nature of the work we are doing to support those aspiring to lead.

"We are excited to announce this partnership with Greenway," said Jerry Shultz, President of Lightbeam Health Solutions, "Lightbeam's synchronized enterprise data warehouse and risk stratification unravels the complexities of clinical and claims data feeding from multiple sources. The predictive modeling will enable Greenway providers to lower the cost of health care by identifying patients with avoidable high-cost events, and the care management capabilities allow timely interventions improving patient health."

"The Greenway Marketplace was developed to speed and simplify the adoption of healthcare innovation," said Greg Shilling, Greenway Vice President of Corporate Development. "We're pleased to partner with Lightbeam Health through the Marketplace to enable our customers to easily evaluate and select solutions such as the Lightbeam Health population management platform that support their success and position them to navigate the future of healthcare."

Lightbeam and Greenway will be launching their partnership at the 2014 Engage User Conference in Grapevine Texas September 4th through the 7th. Learn more at http://www.greenwayhealth.com/engage/.

About Lightbeam Health Solutions, LLC

Lightbeam Health provides visibility and business continuity solutions to healthcare organizations. The flagship analytics platform securely automates the aggregation of multi-source data, applies quality measures and visualizes near-real-time insights. Customers experience:

  • Preservation of patient time with physicians. Point-of-care insights are integrated with your EMR so physicians don't have to waste time toggling between apps.
  • Simplified population and risk analysis and decision-making. Simplicity is the design cornerstone for the dashboard reporting interface.
  • Optimized coordination of care. Integrated geo-mapping enables providers with proximity mapping and planning in delivering care.
  • Improved partnership between provider and payer. Because both claims and clinical data are integrated, insights are more valuable with a more complete view of information.

We invite Group Providers, Healthcare Systems, ACOs and Payers who aspire to lead in transforming a culture to learn more about Lightbeam Health. There are many ways to connect…call 972.831.7270, email us at info@lightbeamhealth.com, visit our website at http://www.lightbeamhealth.com, connect via LinkedIn, or follow us on Twitter.

Contact:
Peter A Snell
Media Representative
214.810.6207
Email

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.